67 citations
,
December 2015 in “Journal of the National Comprehensive Cancer Network” This review summarizes NCCN guidelines for prostate cancer early detection, focusing on strategies to maximize detection of potentially curable cases while minimizing unnecessary procedures, but it reports no new clinical findings.
80 citations
,
November 2017 in “New Phytologist” In this study, the researchers used the dual-flow-RootChip to show that Arabidopsis roots can locally adapt their hair development in response to asymmetric phosphate conditions.
January 2015 in “Faculty of 1000 Research Ltd” BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.
81 citations
,
May 2019 in “Frontiers in Endocrinology” This study found that administering melatonin for 12 weeks to women with PCOS significantly reduced hirsutism, testosterone, and inflammation markers, while enhancing antioxidant levels compared to a placebo.
6 citations
,
March 2024 in “Journal of Clinical Laboratory Analysis” This study reported that IGF2BP2 rs1470579 and IGFBP3 rs2854744 may increase the risk of polycystic ovary syndrome in a Southeastern Iranian population.
December 2025 in “Egyptian Journal of Basic and Applied Sciences” This study found that the JAK1 rs310241 AG genotype is associated with a 4.6-fold increased risk of alopecia areata, whereas JAK2 polymorphisms showed no significant link, suggesting a potential genetic susceptibility factor warranting further research.
December 2024 in “Livers” This case report highlights a female patient with familial partial lipodystrophy who showed significant improvement in liver stiffness after starting leptin replacement therapy.
November 2023 in “Faculty of 1000 Research Ltd” This case report describes a rare instance of tuberculous lymphadenitis in a patient with systemic lupus erythematosus, highlighting the potential link between immune suppression and tuberculosis risk.
January 2023 in “Faculty of 1000 Research Ltd” This report details a case of tuberculous lymphadenitis in a 21-year-old female with SLE, suggesting that immune suppression may increase susceptibility to this extra-pulmonary TB.
January 2023 in “Faculty of 1000 Research Ltd” This case report describes a 21-year-old female with systemic lupus erythematosus who developed tuberculous lymphadenitis, highlighting the risk of TB in patients with weakened immune systems on long-term immunosuppressive therapy.
January 2023 in “Faculty of 1000 Research Ltd” This case report details a 21-year-old female with systemic lupus erythematosus who developed tuberculous lymphadenitis, illustrating how immunosuppressive therapy in SLE patients can lead to such infections.
June 2026 in “Preprints.org” This review examines the mechanisms behind pathological scarring like hypertrophic scars and keloids, highlights the limitations of current treatments, and suggests that biomaterial-enabled delivery of anti-fibrotic statins, such as atorvastatin, may offer a promising therapeutic avenue for managing these scars.
In this review, the authors highlight a lack of understanding regarding the unique properties of Afro-textured hair, emphasizing the need for scientific collaboration to improve hair care practices and mitigate scalp issues.
Genetic differences may influence male pattern hair loss in Russians.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses the pathophysiology, molecular events, and therapeutic options for androgenetic alopecia, but reports no new clinical findings.
This review highlights that managing androgenetic alopecia in women involves a variety of treatments including approved drugs like minoxidil, as well as newer therapies such as PRP and LLLT, yet emphasizes the need for more research on long-term outcomes and treatment standardization.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses various management strategies for androgenetic alopecia in women, including approved drugs like minoxidil and emerging therapies such as PRP and LLLT, highlighting the need for research on long-term outcomes and standardization.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is common, with different types affecting people due to genetics, stress, or autoimmune issues.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is common and varies by type, with androgenetic alopecia being the most prevalent.
March 2026 in “SHILAP Revista de lepidopterología” This review found that cosmeceuticals blend cosmetic and biological skin effects, offering promise in mild dermatoses and photoaging prevention, yet face challenges like regulatory gaps and the need for standardized definitions and pharmacovigilance systems.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses advancements in understanding the genetic and stem cell involvement in androgenetic alopecia, evaluates current treatments, and emphasizes the need for evidence-based guidelines but presents no new clinical results.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses recent advances in the understanding of androgenetic alopecia, focusing on genetic factors and new diagnostic and treatment approaches, but it does not provide new clinical results.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This article explores the various causes of alopecia and provides an overview of treatments such as allopathic, homeopathic, naturopathic, cosmeceutical, and ayurvedic methods, emphasizing recent advancements in addressing hair loss.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This source explores alopecia areata, an immune-mediated disorder causing patchy hair loss due to immunological attacks on hair follicles, with a complex interaction of genetic, environmental, and immunological factors, particularly T-cell-mediated inflammation, contributing to its onset.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review explores the causes and management of premature greying in children, noting it may indicate underlying health issues, and emphasizes structured evaluations and treatments, particularly for nutritional deficiencies and hypothyroidism, to address hair depigmentation.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights concerns around premature greying in children, detailing possible links to nutritional deficiencies and other health issues, and emphasizes that structured evaluation and targeted treatment may aid in reversing the condition.
May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study highlights the potential of forensic DNA phenotyping using Next Generation Sequencing to predict eye, hair, and skin color, aiding criminal investigations, though adoption faces challenges due to incomplete genetic understanding and ethical, social, and legal concerns.
113 citations
,
June 2019 in “F1000Research” This review discusses the mechanisms of wound healing and excessive scarring, highlighting the importance of understanding these processes for developing new therapies to prevent fibrotic scarring in large skin wounds.
104 citations
,
May 2019 in “F1000Research” This review discusses recent research on male infertility causes and treatments, emphasizing the need for further understanding of idiopathic sperm abnormalities and molecular factors to improve patient outcomes; it reports no new clinical results.
29 citations
,
January 2003 in “Genomics” A new mouse mutation causes skin and hair issues, influenced by another gene.